Dexter Tjoa

Earlier this month (9 August) we passed the six-month time point before all companies in Europe will be expected to comply with the falsified medicines directive (FMD). more


A new business has been formed to help with the growing number of companies requiring assistance to meet the forthcoming serialisation requirements and deadlines. more


In this article with EPM, Dexter Tjoa, director of Corporate Strategy, discusses why outsourcing is fast becoming the most logical choice for companies who have delayed developing appropriate solutions and what benefits an experienced CPO can bring more


The introduction of new technologies over the last decade has paved the way for pharmaceutical packaging companies to explore new and innovative solutions, improve their operations and drive efficiencies across the supply chain. Here, Dexter Tjoa, di more


After a preview of TraceLink’s second annual Global Drug Supply, Safety and Traceability survey has revealed disparity in terms of readiness for the FMD between pharma companies and CMOs, three experts give us their perspectives on serialisation more

, , Opinion

Dexter Tjoa, director of corporate strategy, Tjoapack, discusses what he has found challenging and highlights the opportunities he has experienced for the year. more